Ring 1
Ring 2
Ring 3
Ring 4

BiomX

Financing Round

  • Public
Round Led by Symbiosis

BiomX is a clinical-stage microbiome company developing both natural and engineered phage cocktails designed to target and destroy bacteria in the treatment of chronic diseases, such as cystic fibrosis, atopic dermatitis, inflammatory bowel disease, primary sclerosing cholangitis, and colorectal cancer. BiomX discovers and validates proprietary bacterial targets and customizes phage compositions against these targets.

biomX View Website

Modality

  • Biologic

Indications

  • Circulatory & Metabolic Disease
  • Dermatology

Development Status

  • Phase 1

Learn More About BiomX

Name(Required)